HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark D Bednarski Selected Research
Mark D Bednarski Research Topics
Disease
10
Neoplasms (Cancer)
11/2010 - 01/2002
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2007 - 10/2003
1
Head and Neck Neoplasms (Head and Neck Cancer)
09/2007
1
Necrosis
09/2007
1
Carcinoma (Carcinomatosis)
09/2004
1
Glioblastoma (Glioblastoma Multiforme)
11/2003
1
Ischemia
01/2002
1
Inflammation (Inflammations)
01/2002
Drug/Important Bio-Agent (IBA)
2
Oligonucleotides
IBA
09/2007 - 10/2003
2
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
09/2007 - 03/2004
2
Contrast Media
IBA
09/2004 - 08/2003
2
Gadolinium
IBA
09/2004 - 11/2003
1
Histones (Histone)
IBA
11/2010
1
fluorocarbon 77 (Fluorinert)
IBA
11/2010
1
dichlorodifluoromethane (FC 12)
IBA
11/2010
1
Apolipoproteins
IBA
11/2010
1
Luciferases
IBA
05/2009
1
Steam
IBA
05/2009
1
Biological Products
IBA
09/2007
1
deoxyuridine triphosphate
IBA
09/2007
1
Dextrans (Dextran)
FDA Link
02/2005
1
Pharmaceutical Preparations
IBA
02/2005
1
liposomal doxorubicin (Doxil)
FDA Link
02/2005
1
Suspensions
IBA
02/2005
1
Fluorescein (Funduscein)
FDA Link
Generic
02/2005
1
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2005
1
Platelet Endothelial Cell Adhesion Molecule-1
IBA
09/2004
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
09/2004
1
Integrin beta3 (GPIIIa)
IBA
09/2004
1
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
09/2004
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
03/2004
1
Integrin alphaVbeta3
IBA
03/2004
1
Proteins (Proteins, Gene)
FDA Link
11/2003
1
Coloring Agents (Dyes)
IBA
10/2003
1
Hematoxylin (Haematoxylon)
IBA
10/2003
1
Eosine Yellowish-(YS) (Eosin)
IBA
10/2003
Therapy/Procedure
1
Extracorporeal Shockwave Therapy
09/2007
1
Injections
02/2005
1
Subcutaneous Injections
02/2005
1
Radioimmunotherapy
03/2004
1
Lasers (Laser)
11/2003
1
Therapeutics
01/2002